Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Summit Therapeutics PLC (SMMT) vs Bio-Techne Corp (TECH)

Summit Therapeutics PLC and Bio-Techne Corp are both Biotechnology companies. Summit Therapeutics PLC is the larger, with a market value of $13.1B against $11.4B — 1.2× the size. Summit Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 62.1×. Bio-Techne Corp grew revenue faster over the last twelve months: −0.38% against −61.0%. Bio-Techne Corp has the higher net margin (15.0% vs 0.00%) and the higher return on invested capital (7.70% vs 0.00%). Across the 19 metrics below, Bio-Techne Corp leads on 16 and Summit Therapeutics PLC on 3.

Valuation

Metric SMMT TECH Biotechnology median
P/E n/m 62.06 7.88
P/S 17,230.45 9.32 11.47
P/B 19.28 5.37 2.52
Price to free cash flow n/m 43.02 21.16
EV/EBITDA n/m 32.27 0.74
EV/Sales 16,392.16 9.28 10.73
Earnings yield (7.17%) 1.61% (28.84%)
Free cash flow yield (3.79%) 2.32% (23.03%)

Profitability

Metric SMMT TECH Biotechnology median
Gross margin 100.00% 65.77% 65.16%
Operating margin 0.00% 20.73% 0.00%
Net margin 0.00% 14.97% 0.00%
Free cash flow margin 0.00% 21.66% 0.00%
Return on equity (192.50%) 9.03% (57.72%)
Return on assets (159.09%) 7.07% (49.22%)
Return on invested capital 0.00% 7.70% 0.00%

Growth

Metric SMMT TECH Biotechnology median
Revenue growth (TTM) (61.03%) (0.38%) 5.64%
EPS growth (last fiscal year) (364.52%) 152.17% —
Revenue growth, 5-year CAGR (46.49%) 5.47% 8.40%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric SMMT TECH Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 6.96 4.55 4.73
Net debt to EBITDA 0.65 (0.19) 0.96

Dividend

Metric SMMT TECH Biotechnology median
Dividend yield — 0.37% 2.10%
Payout ratio 0.00 0.18 0.00

Size

Metric SMMT TECH Biotechnology median
Market cap 13.12b 11.38b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack